Cellegy Seeks A Buyer Or Partner For Cellegesic Following FDA “Approvable” Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
"Approvable" letter indicates the need for additional studies to provide more evidence of the efficacy of the nitroglycerin ointment for anal fissures.
You may also be interested in...
Missing Clinical Trial Data: "Mixed Model" Approach Gains Ground At FDA
Clinical trial sponsors should adopt a mixed statistical model to cope with missing data rather than relying on the "last observation carried forward" model that was formerly perceived as regulators' favorite
Missing Clinical Trial Data: "Mixed Model" Approach Gains Ground At FDA
Clinical trial sponsors should adopt a mixed statistical model to cope with missing data rather than relying on the "last observation carried forward" model that was formerly perceived as regulators' favorite
Cellegy Contraception Gel Study Continues After Firm Drops HIV Trial
Phase III Nigerian trial was halted after data monitoring committee determines the microbicide was unlikely to show convincing evidence it protects against HIV.